av/jubilant-life-sciences--big.svg

COM:JUBILANTPHARMOVA

Jubilant Pharmova

  • Stock

Last Close

1,138.50

25/11 04:39

Market Cap

115.38B

Beta: -

Volume Today

48.99K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
2.07B
-
403.24M
80.55%
5.84B
1,349.11%
7.38B
26.24%
8.59B
16.46%
9.04B
5.21%
12.11B
33.94%
12.12B
0.12%
6.30B
47.98%
277.80M
95.59%
771M
177.54%
depreciation and amortization
2.81B
-
2.88B
2.41%
3.46B
20.15%
2.91B
15.78%
4.15B
42.43%
3.71B
10.64%
4.62B
24.54%
4.52B
2.23%
3.82B
15.49%
5.54B
45.15%
3.82B
31.07%
deferred income tax
-3.84B
-
-1.40B
63.43%
-2.14B
52.54%
stock based compensation
2.46M
-
11.24M
356.91%
36.50M
224.73%
85M
132.88%
change in working capital
-1.11B
-
964M
187.09%
-1.47B
252.12%
368.79M
125.15%
141.47M
61.64%
-3.01B
2,224.32%
-1.80B
40.21%
2.50B
239.09%
-1.78B
171.34%
543.10M
130.46%
2.53B
366.03%
accounts receivables
-2.05B
-
2.20B
207.30%
-1.13B
151.27%
-721.37M
35.98%
385.53M
153.44%
494M
28.14%
inventory
-1.75B
-
1.10B
163.01%
509.43M
53.80%
-328.82M
164.55%
-1.35B
310.19%
166.87M
112.37%
-3.74B
2,343.23%
1.34B
135.88%
-956.47M
171.21%
-646.80M
32.38%
908M
240.38%
accounts payables
2.05B
-
-251.16M
112.26%
2.28B
1,008.82%
-427.14M
118.71%
2.11B
592.89%
232M
88.98%
other working capital
643.18M
-
-138.65M
121.56%
-1.98B
1,325.08%
697.61M
135.31%
1.49B
113.62%
-3.17B
312.86%
322.11M
-
-1.30B
503.88%
897M
168.95%
other non cash items
4.25B
-
3.59B
15.60%
3.09B
13.93%
2.03B
34.36%
149.22M
92.63%
1.47B
887.34%
501.50M
65.96%
2.55B
407.73%
1.43B
43.83%
2.35B
64.43%
6.68B
184.20%
net cash provided by operating activities
8.03B
-
7.83B
2.41%
10.92B
39.46%
12.68B
16.13%
13.03B
2.74%
11.22B
13.94%
15.43B
37.58%
17.84B
15.64%
8.38B
53.06%
6.61B
21.12%
7.80B
18.08%
investments in property plant and equipment
-2.91B
-
-3.75B
28.96%
-3.56B
5.12%
-4.64B
30.45%
-4.89B
5.36%
-6.56B
34.11%
-5.74B
12.47%
-5.27B
8.13%
-6.00B
13.74%
-8.14B
35.74%
-8.98B
10.22%
acquisitions net
407.11M
-
3.56B
-
4.64B
30.45%
-1.31B
128.12%
-101.69M
92.21%
310.65M
405.49%
131.95M
57.52%
-1.63B
1,333.43%
374.40M
123.00%
97M
74.09%
purchases of investments
-62.52M
-
-41.53M
33.57%
-45.05M
8.48%
-112.33M
149.35%
-195.72M
74.24%
-40K
99.98%
-36.39M
90,875%
-2.02B
5,462.68%
-23.19M
98.85%
-126.50M
445.49%
-76M
39.92%
sales maturities of investments
2.91B
-
302.25M
-
185.89M
38.50%
79.45M
57.26%
6.56B
8,155.86%
235.75M
96.41%
-131.95M
155.97%
2.14B
1,724.87%
8.90M
99.58%
57M
540.45%
other investing activites
-2.09B
-
358.50M
117.16%
-3.52B
1,082.35%
-4.58B
29.98%
135.28M
102.96%
-10.02B
7,504.36%
1.96B
119.58%
-90.94M
104.64%
1.70B
1,972.55%
2.44B
43.50%
2.30B
5.92%
net cash used for investing activites
-1.74B
-
-3.43B
96.84%
-3.26B
4.92%
-4.50B
37.97%
-6.18B
37.15%
-10.12B
63.81%
-3.27B
67.68%
-7.39B
126.00%
-3.80B
48.53%
-5.44B
43.13%
-6.60B
21.31%
debt repayment
-6.23B
-
-27.15B
335.62%
-10.24B
62.29%
-25.39B
147.95%
-6.28B
75.27%
-13.13B
109.07%
-16.10B
22.68%
-19.50B
21.10%
-49.96M
99.74%
-27.73B
55,404.20%
-204M
99.26%
common stock issued
77.37M
-
10.23M
86.78%
2.66B
25,888.76%
2.62M
99.90%
-100.61M
3,940.08%
27.77B
-
common stock repurchased
19.01B
-
16.12B
-
-100.61M
100.62%
-39.70M
-
-274M
590.18%
dividends paid
-552.36M
-
-538.05M
2.59%
-569.27M
5.80%
-558.65M
1.87%
-560.30M
0.30%
-545.86M
2.58%
-1.53B
179.95%
-14.75M
99.03%
-800.53M
5,327.32%
-800.60M
0.01%
-798M
0.32%
other financing activites
2.34B
-
22.66B
869.32%
2.59B
88.59%
2.20M
99.91%
-2.18B
99,319.55%
17.59B
905.72%
-8.99B
151.12%
2.62B
129.16%
524.50M
79.99%
-766.22M
246.09%
net cash used provided by financing activities
-4.45B
-
-5.03B
13.03%
-8.22B
63.59%
-6.86B
16.59%
-9.01B
31.39%
6.57B
172.96%
-10.50B
259.77%
-17.09B
62.74%
-325.99M
98.09%
-1.57B
380.66%
-1.89B
20.49%
effect of forex changes on cash
114.26M
-
-190.92M
267.09%
40.15M
121.03%
-150.48M
474.79%
33.63M
122.35%
-58.83M
274.93%
598.52M
1,117.37%
122.59M
79.52%
572.88M
367.31%
705.30M
23.11%
116M
83.55%
net change in cash
1.94B
-
-818.58M
142.23%
-524.66M
35.91%
1.17B
323.34%
-2.12B
281.15%
7.61B
458.61%
2.25B
70.39%
-7.29B
423.34%
4.82B
166.11%
301M
93.75%
-571.19M
289.76%
cash at beginning of period
2.80B
-
4.73B
69.32%
3.92B
17.29%
3.39B
13.37%
4.56B
34.54%
2.44B
46.50%
10.05B
311.75%
12.31B
22.42%
5.02B
59.22%
9.84B
96.00%
10.14B
3.06%
cash at end of period
4.73B
-
3.92B
17.29%
3.39B
13.40%
4.56B
34.58%
2.44B
46.50%
10.05B
311.75%
12.31B
22.42%
5.02B
59.22%
9.84B
96.00%
10.14B
3.06%
9.57B
5.63%
operating cash flow
8.03B
-
7.83B
2.41%
10.92B
39.46%
12.68B
16.13%
13.03B
2.74%
11.22B
13.94%
15.43B
37.58%
17.84B
15.64%
8.38B
53.06%
6.61B
21.12%
7.80B
18.08%
capital expenditure
-2.91B
-
-3.75B
28.96%
-3.56B
5.12%
-4.64B
30.45%
-4.89B
5.36%
-6.56B
34.11%
-5.74B
12.47%
-5.27B
8.13%
-6.00B
13.74%
-8.14B
35.74%
-8.98B
10.22%
free cash flow
5.12B
-
4.08B
20.24%
7.36B
80.40%
8.04B
9.21%
8.14B
1.22%
4.66B
42.81%
9.69B
108.08%
12.57B
29.73%
2.38B
81.10%
-1.54B
164.74%
-1.18B
23.53%

All numbers in (except ratios and percentages)